UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000019107
Receipt number R000022067
Scientific Title A exploratory study for the effects of antioxidant form of coenzyme Q10 (ubiquinol)
Date of disclosure of the study information 2015/09/24
Last modified on 2019/01/19 19:13:29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A exploratory study for the effects of antioxidant form of coenzyme Q10 (ubiquinol)

Acronym

A exploratory study for the effects of antioxidant form of coenzyme Q10(ubiquinol)

Scientific Title

A exploratory study for the effects of antioxidant form of coenzyme Q10 (ubiquinol)

Scientific Title:Acronym

A exploratory study for the effects of antioxidant form of coenzyme Q10(ubiquinol)

Region

Japan


Condition

Condition

Subjects with tendency of constipation or diarrhea

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effects of antioxidant form of coenzyme Q10 for intestinal environment

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1)The change of defecation and fecal form
2)QOL
3)Cognitive function
These are evaluate in baseline, 12 weeks, and 24 weeks after intervention

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

antioxidant form of coenzyme Q10 (Ubiquinol) 50mg
3 capsuls (150mg) 1 time a day
A group for 24 weeks, B group for 12 weeks

Interventions/Control_2

placebo capsule
3 capsuls1 time a day
B group for 12 weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

60 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The subject are over 60 years old with tendency of constipation or diarrhea

Key exclusion criteria

1) Patients who have allergic to test food
1) Patients who have serious complications
2) Pregnant
3) Others

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Sho Suzuki

Organization

Yuri-Kumiai General Hospital

Division name

Department of Gastroenterology

Zip code


Address

38, Kawaguchiazayago, Yurihonjoshi, Akita, Japan

TEL

0184-27-1200

Email

s.sho.salubriter.mail@gmail.com


Public contact

Name of contact person

1st name
Middle name
Last name Sho Suzuki

Organization

Yuri-Kumiai General Hospital

Division name

Department of Gastroenterology

Zip code


Address

38, Kawaguchiazayago, Yurihonjoshi, Akita, Japan

TEL

0184-27-1200

Homepage URL


Email

s.sho.salubriter.mail@gmail.com


Sponsor or person

Institute

Yuri-Kumiai General Hospital

Institute

Department

Personal name



Funding Source

Organization

KANEKA Coporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 09 Month 24 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 09 Month 09 Day

Date of IRB


Anticipated trial start date

2015 Year 10 Month 01 Day

Last follow-up date

2017 Year 07 Month 08 Day

Date of closure to data entry

2017 Year 07 Month 30 Day

Date trial data considered complete

2017 Year 07 Month 30 Day

Date analysis concluded

2017 Year 08 Month 31 Day


Other

Other related information



Management information

Registered date

2015 Year 09 Month 24 Day

Last modified on

2019 Year 01 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022067


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name